Current status and prospect of PET-related imaging radiomics in lung cancer
Lung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more tha...
Autors principals: | , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Frontiers Media S.A.
2023-12-01
|
Col·lecció: | Frontiers in Oncology |
Matèries: | |
Accés en línia: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/full |
_version_ | 1827580963857629184 |
---|---|
author | Xin Tang Fan Wu Xiaofen Chen Shengli Ye Zhongxiang Ding |
author_facet | Xin Tang Fan Wu Xiaofen Chen Shengli Ye Zhongxiang Ding |
author_sort | Xin Tang |
collection | DOAJ |
description | Lung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more than 80% of cases. Diverse subtypes demand distinct treatment approaches. The application of precision medicine necessitates prompt and accurate evaluation of treatment effectiveness, contributing to the improvement of treatment strategies and outcomes. Medical imaging is crucial in the diagnosis and management of lung cancer, with techniques such as fluoroscopy, computed radiography (CR), digital radiography (DR), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)/CT, and PET/MRI being essential tools. The surge of radiomics in recent times offers fresh promise for cancer diagnosis and treatment. In particular, PET/CT and PET/MRI radiomics, extensively studied in lung cancer research, have made advancements in diagnosing the disease, evaluating metastasis, predicting molecular subtypes, and forecasting patient prognosis. While conventional imaging methods continue to play a primary role in diagnosis and assessment, PET/CT and PET/MRI radiomics simultaneously provide detailed morphological and functional information. This has significant clinical potential value, offering advantages for lung cancer diagnosis and treatment. Hence, this manuscript provides a review of the latest developments in PET-related radiomics for lung cancer. |
first_indexed | 2024-03-08T22:28:38Z |
format | Article |
id | doaj.art-b985c9f1c87d4e06a4b521df87834166 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-03-08T22:28:38Z |
publishDate | 2023-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-b985c9f1c87d4e06a4b521df878341662023-12-18T07:38:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-12-011310.3389/fonc.2023.12976741297674Current status and prospect of PET-related imaging radiomics in lung cancerXin Tang0Fan Wu1Xiaofen Chen2Shengli Ye3Zhongxiang Ding4Department of Radiology, Hangzhou Wuyunshan Hospital (Hangzhou Health Promotion Research Institute), Hangzhou, ChinaDepartment of Nuclear Medicine and Radiology, Shulan Hangzhou Hospital affiliated to Shulan International Medical College of Zhejiang Shuren University, Hangzhou, ChinaDepartment of Radiology, Hangzhou Wuyunshan Hospital (Hangzhou Health Promotion Research Institute), Hangzhou, ChinaDepartment of Nuclear Medicine and Radiology, Shulan Hangzhou Hospital affiliated to Shulan International Medical College of Zhejiang Shuren University, Hangzhou, ChinaDepartment of Radiology, Hangzhou First People’s Hospital, Hangzhou, ChinaLung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more than 80% of cases. Diverse subtypes demand distinct treatment approaches. The application of precision medicine necessitates prompt and accurate evaluation of treatment effectiveness, contributing to the improvement of treatment strategies and outcomes. Medical imaging is crucial in the diagnosis and management of lung cancer, with techniques such as fluoroscopy, computed radiography (CR), digital radiography (DR), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)/CT, and PET/MRI being essential tools. The surge of radiomics in recent times offers fresh promise for cancer diagnosis and treatment. In particular, PET/CT and PET/MRI radiomics, extensively studied in lung cancer research, have made advancements in diagnosing the disease, evaluating metastasis, predicting molecular subtypes, and forecasting patient prognosis. While conventional imaging methods continue to play a primary role in diagnosis and assessment, PET/CT and PET/MRI radiomics simultaneously provide detailed morphological and functional information. This has significant clinical potential value, offering advantages for lung cancer diagnosis and treatment. Hence, this manuscript provides a review of the latest developments in PET-related radiomics for lung cancer.https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/fulllung cancerradiomicspositron emission tomography/magnetic resonance imagingpositron emission tomography/computed tomographyreview |
spellingShingle | Xin Tang Fan Wu Xiaofen Chen Shengli Ye Zhongxiang Ding Current status and prospect of PET-related imaging radiomics in lung cancer Frontiers in Oncology lung cancer radiomics positron emission tomography/magnetic resonance imaging positron emission tomography/computed tomography review |
title | Current status and prospect of PET-related imaging radiomics in lung cancer |
title_full | Current status and prospect of PET-related imaging radiomics in lung cancer |
title_fullStr | Current status and prospect of PET-related imaging radiomics in lung cancer |
title_full_unstemmed | Current status and prospect of PET-related imaging radiomics in lung cancer |
title_short | Current status and prospect of PET-related imaging radiomics in lung cancer |
title_sort | current status and prospect of pet related imaging radiomics in lung cancer |
topic | lung cancer radiomics positron emission tomography/magnetic resonance imaging positron emission tomography/computed tomography review |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/full |
work_keys_str_mv | AT xintang currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer AT fanwu currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer AT xiaofenchen currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer AT shengliye currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer AT zhongxiangding currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer |